We are live on ! Find out more
PCA

Providence Capital Advisors Portfolio holdings

AUM $613M
1-Year Est. Return 17.83%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+17.83%
3 Year Est. Return
+42.1%
5 Year Est. Return
+50.05%
10 Year Est. Return
–
AUM
$321M
AUM Growth
+$11.5M
Cap. Flow
+$16.1M
Cap. Flow %
5.01%
Top 10 Hldgs %
26.2%
Holding
358
New
36
Increased
93
Reduced
39
Closed
39

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$4.11M
2
GLW icon
Corning
GLW
+$4.02M
3
BAX icon
Baxter International
BAX
+$3.78M
4
BSX icon
Boston Scientific
BSX
+$3.65M
5
CSX icon
CSX Corp
CSX
+$3.5M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$4.44M
2
MSFT icon
Microsoft
MSFT
+$3.74M
3
JCI icon
Johnson Controls International
JCI
+$3.69M
4
UPS icon
United Parcel Service
UPS
+$3.39M
5
LOW icon
Lowe's Companies
LOW
+$3.34M

Sector Composition

Rank Sector Weight
1 Technology 22.33%
2 Healthcare 13.54%
3 Financials 12.68%
4 Communication Services 10.01%
5 Consumer Staples 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROST icon
276
Ross Stores
ROST
$81.1B
$3K ﹤0.01%
23
– –
SWK icon
277
Stanley Black & Decker
SWK
$14.8B
$3K ﹤0.01%
18
– –
SPLK
278
DELISTED
Splunk Inc
SPLK
$3K ﹤0.01%
20
– –
KSCD
279
DELISTED
KFA Small Cap Quality Dividend Index ETF
KSCD
$3K ﹤0.01%
108
– –
AMH icon
280
American Homes 4 Rent
AMH
$12.4B
$2K ﹤0.01%
48
– –
ATO icon
281
Atmos Energy
ATO
$28.9B
$2K ﹤0.01%
24
– –
O icon
282
Realty Income
O
$58.7B
$2K ﹤0.01%
36
-207
-85% -$14K
VXRT
283
DELISTED
Vaxart
VXRT
$2K ﹤0.01%
200
– –
PRVB
284
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$2K ﹤0.01%
275
– –
RESN
285
DELISTED
Resonant Inc.
RESN
$2K ﹤0.01%
1,000
– –
ALT icon
286
Altimmune
ALT
$583M
$1K ﹤0.01%
125
– –
ANSS
287
DELISTED
Ansys
ANSS
$1K ﹤0.01%
+2
New +$722
BB icon
288
BlackBerry
BB
$5.2B
$1K ﹤0.01%
75
– –
COMP icon
289
Compass
COMP
$8.97B
$1K ﹤0.01%
70
– –
CVCO icon
290
Cavco Industries
CVCO
$4.2B
$1K ﹤0.01%
6
– –
HWM icon
291
Howmet Aerospace
HWM
$115B
$1K ﹤0.01%
47
– –
KR icon
292
Kroger
KR
$35.7B
$1K ﹤0.01%
18
– –
POST icon
293
Post Holdings
POST
$4.09B
$1K ﹤0.01%
11
– –
RGA icon
294
Reinsurance Group of America
RGA
$15.5B
$1K ﹤0.01%
10
– –
VONG icon
295
Vanguard Russell 1000 Growth ETF
VONG
$44.9B
$1K ﹤0.01%
16
– –
VONV icon
296
Vanguard Russell 1000 Value ETF
VONV
$21.1B
$1K ﹤0.01%
16
– –
VTRS icon
297
Viatris
VTRS
$20.5B
$1K ﹤0.01%
90
-61
-40% -$866
WAB icon
298
Wabtec
WAB
$50.1B
$1K ﹤0.01%
10
– –
AKTS
299
DELISTED
Akoustis Technologies Inc
AKTS
$1K ﹤0.01%
150
– –
ACB
300
Aurora Cannabis
ACB
$175M
$0 ﹤0.01%
2
– –
10 11
12
13 14

Similar funds

PSP
Principal Street Partners Memphis, Tennessee $613M AUM 26.72% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CT
Clearstead Trust Portland, Maine $613M AUM 25.73% 1-Year Est. Return
1SAMC
12th Street Asset Management Company Nashville, Tennessee $611M AUM 27.12% 1-Year Est. Return
VV
Verbena Value Westport, Connecticut $611M AUM
DTL
Dynamic Technology Lab Singapore $615M AUM 11.3% 1-Year Est. Return
FFWA
FRG Family Wealth Advisors Bellevue, Washington $611M AUM 25.92% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Providence Capital Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Providence Capital Advisors held 358 positions worth $321M, up 3.7% from $309M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Providence Capital Advisors deployed $16.1M of net new capital in Q3 2021, opening 36 new positions and adding to 93 existing holdings. Its largest new stake was Boston Scientific: 82,600 shares worth $3.58M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $4.44M trimmed.

  • Providence Capital Advisors's largest Q3 2021 buy was Boston Scientific: 82,600 shares worth $3.58M.
  • Providence Capital Advisors added most to Starbucks in Q3 2021, an estimated $4.11M increase.
  • Providence Capital Advisors's biggest Q3 2021 reduction was Gilead Sciences, cutting an estimated $4.44M.
  • Providence Capital Advisors fully exited Johnson Controls International in Q3 2021, selling an estimated $3.69M.
  • Providence Capital Advisors's ten largest holdings make up 26% of its $321M portfolio in Q3 2021.
  • Providence Capital Advisors opened 36 new positions and closed 39 in Q3 2021.
  • Providence Capital Advisors's portfolio value rose 3.7% quarter-over-quarter to $321M.

Based on Providence Capital Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.